Gilead Sciences, Inc.

NASDAQ: GILD    
Share price (5/3/24): $65.33    
Market cap (5/3/24): $81.3 billion
Search in Documents
Key Exhibits
External Links
13 Gilead Sciences, Inc. Expert Interviews, now on BamSEC.
 Powered by Tegus.

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 87 pages Agreement and Plan of Merger Among: Cymabay Therapeutics, Inc., a Delaware Corporation; Gilead Sciences, Inc., a Delaware Corporation; and Pacific Merger Sub, Inc., a Delaware Corporation Dated as of February 11, 2024
12/34/56
EX-2.1
from SC TO-C 87 pages Agreement and Plan of Merger Among: Cymabay Therapeutics, Inc., a Delaware Corporation; Gilead Sciences, Inc., a Delaware Corporation; and Pacific Merger Sub, Inc., a Delaware Corporation Dated as of February 11, 2024
12/34/56
EX-2.1
from 8-K 81 pages Agreement and Plan of Merger Among: Immunomedics, Inc., a Delaware Corporation; Gilead Sciences, Inc., a Delaware Corporation; and Maui Merger Sub, Inc., a Delaware Corporation Dated as of September 13, 2020
12/34/56
EX-2.1
from SC TO-C 81 pages Agreement and Plan of Merger Among: Immunomedics, Inc., a Delaware Corporation; Gilead Sciences, Inc., a Delaware Corporation; and Maui Merger Sub, Inc., a Delaware Corporation Dated as of September 13, 2020
12/34/56
EX-2.1
from SC TO-C 85 pages Agreement and Plan of Merger Among: Forty Seven, Inc., a Delaware Corporation; Gilead Sciences, Inc., a Delaware Corporation; and Toro Merger Sub, Inc., a Delaware Corporation Dated as of March 1, 2020
12/34/56
EX-2.1
from 8-K 85 pages Agreement and Plan of Merger Among: Forty Seven, Inc., a Delaware Corporation; Gilead Sciences, Inc., a Delaware Corporation; and Toro Merger Sub, Inc., a Delaware Corporation Dated as of March 1, 2020
12/34/56
EX-2.1
from 8-K 88 pages Agreement and Plan of Merger Among: Kite Pharma, Inc., a Delaware Corporation; Gilead Sciences, Inc., a Delaware Corporation; and Dodgers Merger Sub, Inc., a Delaware Corporation Dated as of August 27, 2017
12/34/56
EX-2.1
from SC TO-C 88 pages Agreement and Plan of Merger Among: Kite Pharma, Inc., a Delaware Corporation; Gilead Sciences, Inc., a Delaware Corporation; and Dodgers Merger Sub, Inc., a Delaware Corporation Dated as of August 27, 2017
12/34/56
EX-2.1
from 8-K 76 pages Execution Version Agreement and Plan of Merger Among Pharmasset, Inc., Gilead Sciences, Inc. and Royal Merger Sub Inc. Dated as of November 21, 2011
12/34/56
EX-2.1
from SC TO-C 76 pages Execution Version Agreement and Plan of Merger Among Pharmasset, Inc., Gilead Sciences, Inc. and Royal Merger Sub Inc. Dated as of November 21, 2011
12/34/56
EX-2.5
from 10-Q 4 pages Amendment No. 1 to Agreement and Plan of Merger
12/34/56
EX-2.4
from 10-Q 83 pages Agreement and Plan of Merger by and Among Gilead Sciences, Inc., Gilead Biopharmaceutics Ireland Corporation, Gilead Sciences Limited, Calistoga Pharmaceuticals, Inc. and Shareholder Representative Services LLC, as Stockholders’ Agent Dated as of February 21, 2011
12/34/56
EX-2.3
from 10-K 86 pages Agreement and Plan of Merger Dated as of December 19, 2010 by and Among Gilead Sciences, Inc., Arroyo Merger Sub, Inc., Arresto Biosciences, Inc. and Healthcare Ventures VIII, L.P., as Representative
12/34/56
EX-2.1
from 10-Q 100 pages Agreement and Plan of Merger Dated as of June 23, 2010 by and Among Gilead Sciences, Inc., Cougar Merger Sub, Inc., Cgi Pharmaceuticals, Inc. and Sh Rep, LLC, as Representative
12/34/56
EX-2.2
from 8-K 9 pages Stockholder Agreement
12/34/56
EX-2.2
from SC TO-C 9 pages Stockholder Agreement
12/34/56
EX-2.1
from SC TO-C 76 pages Agreement and Plan of Merger Among: Gilead Sciences, Inc., a Delaware Corporation; Apex Merger Sub, Inc., a Delaware Corporation; and CV Therapeutics, Inc., a Delaware Corporation Dated as of March 12, 2009 Agreement and Plan of Merger
12/34/56
EX-2.1
from 8-K 76 pages Agreement and Plan of Merger Among: Gilead Sciences, Inc., a Delaware Corporation; Apex Merger Sub, Inc., a Delaware Corporation; and CV Therapeutics, Inc., a Delaware Corporation Dated as of March 12, 2009 Agreement and Plan of Merger
12/34/56
EX-2.1
from SC TO-C 60 pages Agreement and Plan of Merger by and Among Gilead Sciences, Inc., Mustang Merger Sub, Inc. and Myogen, Inc. October 1, 2006
12/34/56
EX-2.1
from 8-K 60 pages Agreement and Plan of Merger by and Among Gilead Sciences, Inc., Mustang Merger Sub, Inc. and Myogen, Inc. October 1, 2006
12/34/56